SEQURNA
Company

SEQURNA

Biotechnology Research Se 4 employees
Employees
4

SEQURNA Overview

Headquarters
Se
Website
www.sequrna.com
Industry
Biotechnology Research
Employees
4
Founded
2022
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About SEQURNA

Introducing next-generation RNase inhibitors - ideal for single-cell and in situ RNA-sequencing SEQURNA's RNase inhibitor makes RNA work and sequencing pipelines more accessible, affordable, and sustainable. Unlike competitors’ recombinant RNase inhibitors, the SEQURNA inhibitor is thermostable and can be shipped and stored at room temperature without affecting performance. These features not only simplify shipping and storage logistics, eliminate batch effects, and reduce costs for the user but also enable new and simplified workflows and novel laboratory protocols, including heat cycles. Propel your biotech business or research, and choose a more environmentally sustainable option for RNase inhibition in your RNA-seq workflows, by becoming an early user of SEQURNA’s RNase inhibitor. Our R&D team is keen to assist and advice in the transition. Find out more at www.sequrna.com or email us at info@sequrna.com

SEQURNA Contact Details

People in AeroLeads
1

SEQURNA Org Chart

Sample employees and titles
Name Title Contact
Fredrik Olsson CEO at Genovis
View

Compare Similar Companies to SEQURNA